Page last updated: 2024-10-31

mianserin and Bewilderment

mianserin has been researched along with Bewilderment in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerritsen, AW1
Eklund, K1
Dunbar, GC1
Pinder, RM1
Steffensen, K1

Trials

1 trial available for mianserin and Bewilderment

ArticleYear
Mianserin and imipramine in the treatment of elderly depressed patients.
    Acta psychiatrica Scandinavica. Supplementum, 1985, Volume: 320

    Topics: Aged; Confusion; Depressive Disorder; Dibenzazepines; Double-Blind Method; Female; Humans; Imipramin

1985

Other Studies

1 other study available for mianserin and Bewilderment

ArticleYear
Safety in overdose of mirtazapine: a case report.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:6

    Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Confusion; Depressive Disorder; Dothiepin; Drug Ov

1997